StockData
Lucid Diagnostics Inc. logo

Lucid Diagnostics Inc. (LUCD) stock

LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3034% above fair value
$0.41+0.01 (+2.18%)

Close on Nov 18, 2026Market cap $82.86MP/E –Yield –

Lucid Diagnostics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Lucid Diagnostics's revenue for the twelve months ending Jun 30, 2026 was $5.45M, up 24.9% year over year. For fiscal 2025 it was $4.71M, up 8.3% from the year before. The highest annual figure on record is $4.71M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.71M+8.3%
FY2024Dec 31, 2024$4.35M+79.0%
FY2023Dec 31, 2023$2.43M+544.0%
FY2022Dec 31, 2022$377.00K-24.6%
FY2021Dec 31, 2021$500.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.47M+26.7%
Q1 FY2026Mar 31, 2026$1.26M+51.7%
Q4 FY2025Dec 31, 2025$1.50M+25.6%
Q3 FY2025Sep 30, 2025$1.21M+3.3%
Q2 FY2025Jun 30, 2025$1.16M+19.2%
Q1 FY2025Mar 31, 2025$828.00K-17.3%
Q4 FY2024Dec 31, 2024$1.20M+15.1%
Q3 FY2024Sep 30, 2024$1.17M+49.7%
Q2 FY2024Jun 30, 2024$976.00K+513.8%
Q1 FY2024Mar 31, 2024$1.00M+124.4%
Q4 FY2023Dec 31, 2023$1.04M+828.6%
Q3 FY2023Sep 30, 2023$783.00K+930.3%
Q2 FY2023Jun 30, 2023$159.00K–
Q1 FY2023Mar 31, 2023$446.00K+136.0%
Q4 FY2022Dec 31, 2022$112.00K-62.7%
Q3 FY2022Sep 30, 2022$76.00K-62.0%
Q2 FY2022Jun 30, 2022$0–
Q1 FY2022Mar 31, 2022$189.00K–
Q4 FY2021Dec 31, 2021$300.00K–
Q3 FY2021Sep 30, 2021$200.00K–

More Lucid Diagnostics figures

See a number that looks wrong?